These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 14616130

  • 1. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients.
    Wenzel J, Meissner-Kraemer M, Bauer R, Bieber T, Gerdsen R.
    Allergy; 2003 Nov; 58(11):1176-9. PubMed ID: 14616130
    [Abstract] [Full Text] [Related]

  • 2. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P.
    J Investig Allergol Clin Immunol; 2006 Nov; 16(2):79-85. PubMed ID: 16689180
    [Abstract] [Full Text] [Related]

  • 3. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011 Nov; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 4. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L, Chelminska M, Kuziemski K, Skrzypski M, Niedoszytko M, Damps-Konstanska I, Szymanowska A, Siemińska A, Wajda B, Drozdowska A, Jutel M, Jassem E.
    Int Arch Allergy Immunol; 2008 Nov; 147(3):241-5. PubMed ID: 18594155
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM, Kagerer M, Cozzio A, Angelova-Fischer I, Guenova E, Ballmer-Weber B, Hoetzenecker W.
    Int Arch Allergy Immunol; 2020 Nov; 181(10):783-789. PubMed ID: 32781451
    [Abstract] [Full Text] [Related]

  • 6. Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush.
    Selcuk A, Baysan A, Yesillik S, Demirel F, Kartal O, Gulec M, Musabak U, Sener O.
    Ann Med; 2022 Dec; 54(1):2321-2325. PubMed ID: 36111408
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 Dec; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 9. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008838. PubMed ID: 23076950
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
    Sturm G, Kränke B, Rudolph C, Aberer W.
    J Allergy Clin Immunol; 2002 Dec 17; 110(6):928-33. PubMed ID: 12464961
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.